The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study
| Autor: | Yi, L., Ning, Z., Xu, L., Shen, Y., Zhu, X., Yu, W., Xie, J., Meng, Z. |
|---|---|
| Zdroj: | In ESMO Open February 2024 9(2) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|